UnitedHealth Group Incorporated (UNH) Stock Forecast
UNH analyst forecast
as of October 18, 2026- Analyst consensus
- Buy 4.42 / 5 from 26 analysts
- Price target
- $477.04 average of analyst targets
- Upside to target
- +18.8% from the latest close
- Next earnings
- —
- 52-week range
- $259.02 – $436.35
UNH analyst ratings
26 analystsNumber of analysts at each rating.
UNH price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
UNH earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $4.14 | $3.90 | $4.56 | $2.92 | +41.8% | 23 |
| Next quarter (Mar '27) | $8.17 | $6.53 | $9.06 | $7.23 | +13.0% | 16 |
| Current fiscal year (2026) | $20.51 | $19.76 | $20.95 | $16.35 | +25.5% | 25 |
| Next fiscal year (2027) | $23.23 | $20.38 | $24.32 | $20.51 | +13.2% | 26 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
UNH revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $111.49B | $108.49B | $114.00B | −1.5% | 18 |
| Next quarter (Mar '27) | $113.79B | $109.70B | $117.62B | +1.8% | 9 |
| Current fiscal year (2026) | $448.67B | $443.50B | $451.84B | +0.2% | 20 |
| Next fiscal year (2027) | $463.78B | $452.55B | $476.31B | +3.4% | 21 |
UNH EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
UNH revenue: reported and forecast
UNH EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $3.74 | $4.12 | $4.12 | $4.15 | $4.14 | +10.6% | 2 up · 1 down |
| Next quarter (Mar '27) | $8.05 | $8.12 | $8.12 | $8.13 | $8.17 | +1.5% | 1 up · 0 down |
| Current fiscal year (2026) | $19.58 | $19.81 | $19.81 | $19.87 | $20.51 | +4.8% | 2 up · 0 down |
| Next fiscal year (2027) | $22.15 | $22.44 | $22.55 | $22.61 | $23.23 | +4.9% | 2 up · 1 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
UNH earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; UNH beat in 10 of 12.
What analysts expect from UNH
26 analysts cover UnitedHealth; their consensus rating is buy (4.42 on a 1–5 scale, where 5 is a strong buy). The average price target is $477.04, 18.8% above the latest close of $401.43. Analysts expect earnings of $20.51 per share for 2026, +25.5% from a year earlier. For 2027 the average estimate is $23.23 per share on revenue of $463.8 billion. UnitedHealth beat the EPS estimate in 10 of the last 12 quarters.
Related: UNH income statement, UNH key metrics, UNH chart. See the UNH stock overview for the latest quote and news.
UNH forecast FAQ
What is UnitedHealth's price target?
The average analyst price target for UnitedHealth is $477.04, 18.8% above the latest close of $401.43.
Is UnitedHealth a buy, hold or sell?
Of 26 analysts covering UnitedHealth, 15 rate it a strong buy, 7 a buy, 4 a hold, 0 a sell and 0 a strong sell, a consensus of buy. Ratings are opinions, not a recommendation from Quotelinks.
What is UnitedHealth's EPS forecast?
Analysts forecast $20.51 per share for 2026 (range $19.76 to $20.95); for 2027 the estimate is $23.23.
What is UnitedHealth's revenue forecast?
The average revenue estimate for 2026 is $448.7 billion, growth of 0.2%; for 2027 it is $463.8 billion.
Does UnitedHealth usually beat earnings estimates?
UnitedHealth reported EPS at or above the analyst estimate in 10 of the last 12 quarters.